Bangkok, Thailand – VIV Asia, the world’s leading event for the animal protein production industry, announces that visitor registration for the 2025 edition is now open. Set to take place from March 12–14, 2025, at the IMPACT Exhibition and Convention Center in Bangkok, in co-location with MeatPro Asia, and HortiAgriNext Asia 2025, this highly anticipated event promises an expanded and dynamic experience for its global crowd.

New! Expanded Venue

This year, VIV Asia 2025 has expanded into new halls, right across Challenger 1,2 and 3 and will be complemented by the first edition of Horti Agri Next Asia, next to a Features Hall and a dedicated Hall for the CropTech- FeedTech sector.

Focus on Key Industry Themes: Regenerative Agriculture & Animal Disease Management

The 2025 edition will highlight two major themes driving the future of the industry – Regenerative Agriculture and Animal Disease Management.
Regenerative Agriculture is increasingly vital as the industry seeks sustainable and eco-friendly farming practices that promote soil health, biodiversity, and long-term productivity.

Animal Disease Management remains a top priority, with a focus on preventing and controlling outbreaks to ensure the health and safety of livestock populations globally. Attendees will have the opportunity to explore cutting-edge solutions in these areas, participate in dedicated sessions, and network with leading experts.

Aquatic Pavilion: A new area focusing on Aquaculture

Building on previous success, the Aquatic Pavilion has grown significantly for 2025, encompassing not only fish but also shrimp as key species. The pavilion will also feature an enhanced content program designed to address the latest trends, innovations, and challenges in aquaculture, making it a must-visit for professionals in the aquatic sector. With over 17% of last edition’s visitors stating that their company is mainly related to Fish and Shrimps as a specie, the aquatic pavilion is expected to be a new center of attention in 2025.

New Start-up Hub Pavilion

For the first time, and in a bid to support innovation and entrepreneurship, VIV Asia 2025 introduces the Start-up Hub Pavilion. This new platform offers young companies in the industry a plug-and-play solution, providing them with access to global audiences and key stakeholders at the world’s most important event for the animal protein production sector.

Register Now

https://www.databadge.net/viva2025/reg/viv/?card=10000372

VIV Asia 2025 is set to be the most comprehensive edition yet, with unparalleled networking opportunities, cutting-edge content programs, and a platform that spans the full value chain of animal protein production. Interested attendees are invited to pre-register as early as possible to secure their entrance ticket free of charge. Tickets will remain free for visitors who register online until the 11^th of March (23:59, BKK Time).

Visit the show’s website www.vivasia.nl for more information and to remain updated on all news related to VIV Asia.

About VIV worldwide
VIV worldwide is the business network linking professionals from Feed to Food, offering boundless opportunities to the animal protein supply chain players. VIV worldwide developed with dedication a network through 40 years of experience and interactions with the industry, becoming today the leading platform in and for some of the most promising markets of the world. Visit www.viv.net.

About Horti Agri Next Asia (HAN Asia)
HAN Asia is the Horti Agri Next hub edition tailored specifically for the Asian market, showcasing the latest in horticultural food production, landscaping, controlled environment practices, environmental conservation, and agriculture. HAN Asia brings together industry professionals and experts from across Asia and around the world. Join us at HAN Asia to explore the forefront of the Asian horticultural and agricultural industries. For more details, please visit the official website at www.hortiagrinext.com .

About Meat Pro Asia | Meat Pro Asia is a professional trading platform for food processing machinery and packaging technologies. Organised alongside with VIV Asia, the fairs provide the complete supply chain from feed to food to processing and packaging and sales, attracting then entire spectrum of food technology trade buyers in ASEAN region. For more information, please visit the official website at www.meatpro-asia.com

About VNU Group | VNU Group is a globally operating exhibition company with offices in Utrecht (VNU Europe) and Bangkok (VNU Asia Pacific). VNU Group is part of the Royal Dutch Jaarbeurs and represents its international exhibition business outside of the Netherlands. Each VNU office runs a portfolio of exhibition and conference brands with professional expertise on specific markets and industries. The Agri-food exhibition portfolio is a core business in both VNU regional offices. Other VNU Group main event sectors include Tech, Lifestyle, Construction, Lifesciences, Biotech, and more.

About VNU Europe | VNU Europe is a subsidiary company of Royal Dutch Jaarbeurs with its base in Utrecht, at the heart of the Netherlands and only 30 minutes from Amsterdam. The VNU Europe office is located within the extensive Jaarbeurs complex. The international team of VNU Europe is wholly involved in the agrifood sector, focusing on the organization of worldwide industry events such as VIV and Horti Agri Next. For more information, visit www.vnueurope.com

About VNU Asia Pacific | VNU Asia Pacific is part of VNU Group, a globally operating exhibition company with offices in Utrecht, Shanghai, Bangkok and consolidates the international exhibition business of Royal Dutch Jaarbeurs. In Southeast Asia, Jaarbeurs formed a Joint Venture with TCC Group, a leading corporate conglomerate in the fast-growing region. From its business hub located in Bangkok, VNU Asia Pacific covers all key exhibition markets in South East Asia. VNU Asia Pacific has a constantly expanding portfolio with currently 19 trade shows and event formats both online and face-to-face platforms including brands from the AgriTech, Animal Husbandry, Animal Companion, Food, Life Sciences, Biotechnology, 5G and IoT and Disaster Resilience industries. For more information, visit www.vnuasiapacific.com

Zoetis Expands Hyderabad Capability Center, Strengthens Global Animal Health Innovation

Hyderabad September 10: Zoetis Inc. the world’s leading animal health company today announced a significant expansion of its India Capability Center in Hyderabad. This move marks a pivotal step in advancing global animal healthcare through cutting-edge technology.

The ribbon-cutting ceremony, attended by Hon’ble Minister for IT, E&C, Industries & Commerce and Legislative Affairs, Govt of Telangana, showcased Zoetis’ commitment to fostering innovation in animal health and contributing to India’s burgeoning veterinary sector. The expanded center is set to create several hundred new high-skilled jobs by the end of 2025.

Sri D. Sridhar Babu, Minister for IT, E&C, Industries & Commerce and Legislative Affairs, Govt of Telangana, said, “I am delighted to inaugurate the Zoetis India Capability Center’s brand-new office in Hyderabad. This expansion of Zoetis, the world’s largest animal health company, is a testament to Telangana’s emergence as a hub for specialized life sciences and technology talent. This investment not only creates jobs but also positions our state at the forefront of the global healthcare revolution and as the destination for One-Health. I am excited to see how they will leverage our local expertise to drive worldwide innovations in veterinary care and we will offer all support to them to grow from this dynamic city.”

Keith Sarbaugh, Chief Information Officer at Zoetis, said, “This expansion is a cornerstone of our global strategy to harness technology for better animal health outcomes. By tapping into India’s world-class tech and digital talent and vibrant start-up ecosystem, we’re accelerating our ability to deliver breakthrough solutions for veterinarians, pet owners, and livestock farmers across the globe. Hyderabad will play a crucial role in driving our digital transformation and cementing our position as the tech leader in animal health.”

As the premier global Capability Center dedicated to animal health in India, the facility underscores Zoetis’ industry leadership and its recognition of India’s critical role in the global veterinary landscape. The global animal health market is projected to grow at a rate of 4-6% in the next five to ten years. This growth is driven by increasing pet ownership, growing medicalization of companion animals, and rising global demand for animal protein.

As the leader in animal health, Zoetis has invested more in research and development than any other company in the animal health industry and has consistently increased its R&D investment over the last several years, reaching $613 million in 2023. This investment fuels the company’s focus on science-driven innovation that has led to the creation and growth of new markets to address unmet medical needs.

Anil Raghav, Vice President and Head of Zoetis India Capability Center, added, “Our Hyderabad center is poised to become a global powerhouse for veterinary technology innovation. We’re not just expanding our physical presence; we’re creating a nexus where India’s top tech talent will directly impact the future of animal health worldwide. From AI-driven diagnostic tools to industry-leading digital solutions for veterinarians and pet owners, the technology developed here will allow Zoetis to advance its vision to shape the future of animal care globally.”

(Source : https://www.apnnews.com/)

Innovations and Challenges in Poultry Health: A Conversation with Dr. Marc Cayol

Poultry Creations Magazine is excited to present an exclusive interview with Dr. Marc Cayol, the Global Animal Health Director at Andreas Pintaluba S.A. (APSA). With a Ph.D. in Physiology and over 28 years in animal health, Dr. Cayol began his career at Pfizer Animal Health, which later became Zoetis, where he played a pivotal role in the development and introduction of vaccines for ruminants and swine across various regions.

Since joining APSA in 2016, he has led significant advancements in livestock nutrition and health. In this interview, Marc shares insights from his career, discusses APSA’s efforts to reduce antibiotic use, and highlights their collaboration with Nanovet Nutrition in India.

This exclusive interview features a compelling conversation with one of the leading experts in animal health.

Poultry Creations: Can you tell us about your journey in the animal health industry, from your beginnings at Pfizer Animal Health to your current role at Andrés Pintaluba SA?Dr. Marc: After completing my Ph.D. in Biochemistry/Physiology, I immediately began my career in the animal health industry at Pfizer Animal Health, which later became Zoetis. Over 20 years, I held various roles in commercial, technical, and marketing capacities. I started with the French organization, moved to the US for a year, and then returned to work at the international level. In 2016, I joined Andrés Pintaluba SA, a well-known European company based in Reus, Spain. Andrés Pintaluba SA (APSA) is part of the larger Pintaluba Group. We manufacture and distribute our products worldwide.

Poultry Creations : As the Global Animal Health Director at APSA, what are your main responsibilities and daily activities?
Dr. Marc: Each day brings new challenges. With the production and distribution of products in many countries, we face a variety of tasks daily. Being a company that manufactures its own products makes things easier. However, I am not alone in this; we work as a team. This includes the Manufacturing, Regulatory, and Export Departments, as well as our laboratory. Additionally, we have Area Managers from the Health Division, each managing a specific zone in the world. We also have one Area Manager based in India.

Poultry Creations: What are some of the strategic initiatives you have implemented at APSA to enhance animal health solutions?
Dr. Marc: There are two aspects to this question:
1. From a supply standpoint, with the increasing demand for our products, I have contributed to a strategic decision to increase our production capacity. This has resulted in LEK Veterina, a company based in Slovenia, joining the Pintaluba Group. This represents a significant step forward in increasing production capacity for liquid products, vitamin and mineral premixes, and gaining access to technology for manufacturing nutritional products such as water-soluble powders.

2. From a product standpoint, one of the key initiatives has been the introduction of the ApsaGut solution in many countries. ApsaGut is a range of products based on esterified fatty acids designed to optimize intestinal health.

Poultry Creations: What major trends do you see currently shaping the poultry health industry, particularly in regions like Asia, Europe, Africa, and the Middle East?
Dr. Marc: There are many companies producing products and solutions for animal health and poultry farms, with production taking place in diverse territories. I am observing two trends that often conflict with each other. End users and farmers sometimes look for the cheapest options, but they are also sensitive to quality. Not all products available on the market can claim the same quality standards that we, as a European company, have to follow. The value we bring is that Andrés Pintaluba Group holds certifications such as GMP, ISO, FAMI-QS, etc. Therefore, while the price of our products may not be the cheapest, customers are realizing that we supply high-quality products that benefit their animals and the economic viability of their farms.

Poultry Creations: What are the biggest challenges facing poultry health today and how is APSA addressing these challenges?
Dr. Marc: The biggest challenge that the poultry industry is facing globally is the required reduction in the use of certain products like antibiotics, alongside the consumer demand for healthy food. Antibiotics will never be banned as they are essential for the survival of animals, but prudent use should guide every farm to ensure their availability in the long run. In India, APSA is commercializing feed supplements administered in drinking water and feed. We are also considering registering some treatment products. Additionally, we have developed solutions that can be used preventively to at least reduce, if not replace, the use of antibiotics. ApsaGut is a good example of how APSA is addressing these current challenges. It aims to manage intestinal health while reducing the use of antibiotics in prevention.

Poultry Creations: How you see development in Indian market? What are the initiative you are looking into.
Dr. Marc: I visit India regularly and see a strong demand for innovative and natural solutions. The market is evolving towards more sustainable and efficient practices. We are focusing on developing products that meet these needs, including natural health solutions and partnerships with local organizations to address specific challenges and enhance farm productivity.

Poultry Creations: Could you please elaborate more about collaboration with Nanovet Nutrition in India. What initiative both the companies are going to take to add value to Indian producers.
Dr. Marc: APSA and Nanovet Nutrition are joining forces in India to focus on the key segment of gut health. APSA will supply the products, while Nanovet leverages its extensive network of customers and professionals to promote the benefits of our solutions, such as ApsaGut. Without Nanovet, it would be challenging for us to effectively conduct technical promotion in a country like India. Through Nanovet’s field presence and customer connections, we are confident that our solutions will reach a wide range of producers, delivering significant benefits to their operations.

Poultry Creations: What advancements do you foresee in the next five to ten years in the field of poultry health?
Dr. Marc: In any R&D project, it is challenging to predict which specific projects will successfully translate into products. However, as mentioned before, the field of investigation is definitely moving towards natural and effective solutions.

Poultry Creations: What advice would you give to young professionals aspiring to enter the animal health industry?
Dr. Marc: I don’t have direct experience running a farm, but I view it as a vital market segment since we all play a role in feeding the world, and producers have an important role in this chain. Having spent 28 years working in the animal health industry, I can say that it is a field I know and enjoy. It offers the opportunity to interact with people from diverse countries, making it a rewarding career. Being part of this industry means contributing to the food chain and making a significant impact.

Poultry Creations: How do you view the current state of the poultry market in India, and what potential do you see for growth and improvement?
Dr. Marc: I cannot make a definitive judgment on the current state of the poultry market in India. However, as we observe in many markets, the trend is moving towards greater integration of poultry farms. This shift is likely to offer advantages for farmers but will also introduce more constraints, particularly in terms of performance and biosecurity, which they need to be prepared for.

Poultry Creations: What message or suggestions would you like to give to Poultry Creations Magazine to help us improve and better serve our readers in the poultry industry?
Dr. Marc: I discovered Poultry Creations Magazine during a week spent in Haryana and found it very interesting. The magazine offers valuable tips, shared experiences, and technical articles. It provides a good mix of information for readers. Congratulations to the PCM Team for producing such an informative publication.

The veterinary healthcare sector in India is experiencing significant growth, with the market size estimated to be USD 1.25 billion in 2024, projected to reach USD 1.89 billion by 2029, indicating a robust CAGR of 8.63% during the forecast period. This growth is particularly notable in the poultry industry, which has emerged as one of the fastest-growing sectors among livestock species. The poultry sector has evolved into a key supplier of affordable protein sources, driving the development of value chains that cater to consumer demand.

Stallen South Asia: Leading by Change and Setting a Standard
In response to this market dynamic, Stallen South Asia Private Limited has emerged as a key player, offering indigenous solutions and expertise in animal health. By bridging the gap between global standards and local requirements, companies like Stallen are not only contributing to the growth of the poultry industry but also fostering a resilient and sustainable ecosystem for animal health management in the country.

Stallen stands out as a leading name in India’s animal health sector, offering a diverse range of products tailored for poultry and cattle across four distinct divisions. These divisions encompass feed additives, biosecurity solutions, formulations, and vaccines, showcasing Stallen’s comprehensive approach to animal health management.

Stallen’s new Therapeutic Facility

Strategic Collaborations and Industry Partnerships – 25 Years in the Marking
The company’s journey traces back to its inception in 1997. Since inception, Stallen has constantly developed to stay in line with the industry standard – in 2010 Stallen entered a JV with FATRO from Bologna, Italy. This JV enabled Stallen to import and distribute a wide range of killed and live vaccines, further solidifying its position in the market.

Dedicated Storage at the Palghar Facility

Global Reach and Market Presence
Over the 25 years, Stallen has expanded its footprint and capacities. Today, Stallen’s export operations span more than 50 countries across 6 continents serving as a testament to our product quality and service.

In an attempt to completely self suffienct, Stallen has backward integrated and control the end-to-end supply chain. As a result, they currently operate 5 different manufacturing locations in addition to the 2 supply plants of FATRO:
1) Feed Additives Manufacturing Unit in Palghar, Maharashtra
2) Feed Additives Manufacturing Unit in Sajjanpada, Maharashtra
3) Feed Additives and Cattle Feed Premix Manufacturing Unit in Alexandria, Canada
4) Therapeutics/Formulations Manufacturing Unit in Nandore, Maharashtra
5) Halquinol API Manufacturing Unit in Vatva, Gujarat

Focus on Quality and Regulatory Compliance
All of Stallen’s plants are certified and regularly audited by ISO, GMP, and FDA, along with approvals from international regulatory bodies, attestesting to their adherence to rigorous standards in manufacturing and product safety.

1) Feed Additives and Premix Factories in Maharashtra
Stallen South Asia Pvt. Ltd., based in Nandore, Maharashtra, India, specializes in manufacturing a wide range of feed additives and supplements. Their product portfolio includes antibacterial solutions, treatments targeting mycoplasmal infections, deworming agents, performance enhancers, anthelmintics, mineral supplements, toxin-binding formulations, antidiarrheals, growth promoters, anticoccidials, water sanitation products, fly control solutions, and disinfectants. These products are meticulously crafted and made available in various convenient forms such as tablets, boluses, powders, oral liquid solutions.

GMP Standard Manufacturing Layouts

1. Manufacturing Process: The factory has specialized equipment and facilities for the manufacturing process. This includes mixing and blending equipment for creating formulations, granulation machinery for solid products, liquid mixing and filling lines for liquids, and packaging lines for various forms of products.
2. Quality Assurance: Quality control measures are integral to the manufacturing process. Raw materials are tested for purity and quality before use. During production, in-process checks are conducted to ensure consistency and adherence to specifications. Finished products undergo rigorous quality testing for efficacy, safety, and compliance with regulatory standards.
3. Regulatory Compliance: The factory operates in compliance with regulatory requirements set by local and international regulatory bodies, with approvals from China, Iran, Australia and more. This includes adherence to Good Manufacturing Practices (GMP) and documentation of processes to ensure product quality and safety.

2) Formulation Unit in Palghar, Maharashtra, India.
It is a crucial facility for manufacturing pharmaceutical products that range between regular therapeutic drugs as well as beta-lactam formulations.
1. Facilities and Equipment: The formulation unit is equipped with state-of-the-art facilities and machinery required for the formulation and production of pharmaceutical products. This includes equipment for mixing, blending, granulation, drying, and packaging. The capacities are built for effervescent tablets, liquid form (oral and topical), oral powder, bolus and ointment.
2. Quality Control: Throughout the formulation process, rigorous quality control measures are implemented to ensure that the final product meets regulatory standards and specifications. This includes testing the raw materials, in-process samples, and the finished product for purity, potency, stability, and safety.
3. Regulatory Compliance: The formulation unit operates in compliance with regulatory requirements set by authorities such as the Food and Drug Administration (FDA) in India. This includes adherence to Good Manufacturing Practices (GMP), documentation of processes, and regular inspections to ensure quality and safety standards are maintained.

3) “Stallen Unveils Cutting-Edge API Facility for Halquinol Production!”
To maintain its commitment to quality, affordability, and timely delivery, Stallen has commenced the production of Halquinol, a non-antibiotic growth promoter classified under hydroxy-quinolines. This compound comprises 5-chloro-8-hydroxyquinoline, 5,7-Dichloro-8-hydroxyquinoline, and 7-Chloro-8-hydroxyquinoline, with the product Halquinol 98% manufactured in accordance with BP 80 (British Pharmacopeia 1980) specifications. Stallen offers Halquinol 98% as a chemical API for use in veterinary formulations and feed additives, alongside the commonly available 60% and 12% variants. With its adherence to BP specifications and increased monthly production capacity, Stallen is well-equipped to cater to global demand, holding valid registrations for Halquinol in over 15 countries.

Stallen’s strategic vision includes gradually introducing a range of APIs from its Vatva facility, aiming to reduce reliance on imported products from China in the animal health sector. The Vatva plant marks the fifth addition to Stallen’s manufacturing infrastructure, complementing its existing feed additive and veterinary formulation facilities in Palghar, Maharashtra, as well as a feed premix and additive manufacturing unit in Canada. This strategic expansion underscores Stallen’s commitment to self-sufficiency and quality assurance in delivering essential solutions for animal health and nutrition.

Stallen Cutting-Edge API Facility for Halquinol Production!